What's new? Log in Free sign up

Afya Limited (AFYA)

Company Profile

Company profile

Ticker

AFYA

Exchange

Website

www.afya.com.br

CEO

Mr. Virgilio Deloy Capobianco Gibbon

Incorporated

Location

Fiscal year end

Sector

Educational Services > Drugs and Druggists' Sundries Merchant Wholesalers

Industry (SIC)

Services - Educational Services

Graham • Adtalem Global Education • New Oriental Education & Technology • Grand Canyon Education • Zovio • Stride • Perdoceo Education • Sunlands Technology • 17 Education & Technology • Gaotu Techedu ...

SEC CIK

Corporate docs

Articles of Incorporation & Bylaws

Underwriting Agreements

Plans of Reorganization

Material Contracts & Credit Agreements

Subsidiaries Lists

AFYA stock data

1M 3M 6M 1Y

Analyst ratings and price targets

Last 3 months

Average target

$18.25

Low target

$16.00

High target

$20.50

Latest filings (excl ownership)

View all

Afya Limited Announces Entering into a Share Purchase Agreement

Afya Limited Third Quarter and Nine Months 2024 Financial Results

Current report (foreign)

Afya Limited Announces MEC Decision on Medical Seats Reconsideration in Unigranrio

Afya Secures Full Disbursement of R$500 Million from Ifc to Support the Company’s Expansion

Current report (foreign)

Afya Limited Announces Second-Quarter and First-Half 2024 Financial Results

Afya Secures Loan of Up to R$500 Million from Ifc to Support the Company’s Expansion

Afya Limited Announces Medical Seats Increase in UNIMA Alagoas

Afya Limited Announces Closing of the Acquisition of

Transcripts

View all

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Earnings call transcript

Latest ownership filings

View all

de Carvalho Lilian Tavares Esteves

Esteves Vanessa Tavares

Esteves Nicolau Carvalho

de Carvalho Lilian Tavares Esteves

Esteves Renato Tavares

Bertelsmann SE & Co. KGaA

Bertelsmann SE & Co. KGaA

Bertelsmann SE & Co. KGaA

Bertelsmann SE & Co. KGaA

Financial summary

Financial statements Chart AFYA financial data

Quarter (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 23	Dec 22	Dec 21	Dec 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Institutional ownership, Q2 2024

AFYA institutional ownership history Ownership history

79.1% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	67	66	+1.5%
Opened positions	14	56	-75.0%
Closed positions	13	2	+550.0%
Increased positions	17	2	+750.0%
Reduced positions	25	2	+1150.0%

13F shares	Current	Prev Q	Change
Total value	212.84 bn	225.39 bn	-5.6%
Total shares	71.33 mm	71.64 mm	-0.4%
Total puts	100.00	0.00	NEW
Total calls	900.00	16.60 k	-94.6%
Total put/call ratio	0.1	–	–

Largest owners	Shares	Value	Change
Bertelsmann SE & Co. KGaA	36.98 mm	$0.00	0.0%
Esteves Nicolau Carvalho	16.82 mm	$0.00	0.0%
FMR	3.44 mm	$60.68 bn	+13.3%
Bamco	2.70 mm	$47.68 bn	-8.9%
SFTBY SoftBank	2.43 mm	$42.95 bn	0.0%
Esteves Vanessa Tavares	1.78 mm	$0.00	0.0%
de Carvalho Lilian Tavares Esteves	1.78 mm	$27.98 mm	0.0%
Esteves Renato Tavares	1.78 mm	$27.98 mm	0.0%
Perpetual	632.43 k	$11.16 bn	-6.4%
Marshall Wace	336.99 k	$5.95 bn	+41.8%

Largest transactions	Shares	Bought/sold	Change
FMR	3.44 mm	+404.81 k	+13.3%
Massachusetts Financial Services	0.00	-328.55 k	EXIT
Bamco	2.70 mm	-265.18 k	-8.9%
Credit Suisse	0.00	-264.06 k	EXIT
Marshall Wace	336.99 k	+99.42 k	+41.8%
Millennium Management	291.16 k	+90.38 k	+45.0%
AMP Ameriprise Financial	32.94 k	-80.06 k	-70.9%
Renaissance Technologies	266.50 k	+43.80 k	+19.7%
Citadel Advisors	56.66 k	+43.43 k	+328.4%
Perpetual	632.43 k	-43.30 k	-6.4%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

News

From Benzinga Pro

11 Consumer Discretionary Stocks Moving In Monday's Pre-Market Session

JP Morgan Maintains Neutral on Afya, Lowers Price Target to $20.5

JP Morgan analyst Marcelo Santos maintains Afya (NASDAQ:AFYA) with a Neutral and lowers the price target from $25 to $20.5.

Afya To Acquire Faculdade Única De Contagem For R$100M, Adding 60 Medical School Seats In Minas Gerais With Potential For 60 More, Targeting R$52.4M Annual Revenue And 3.3x EV/EBITDA By 2030

Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that it has entered into a share purchase

Goldman Sachs Initiates Coverage On Afya with Sell Rating, Announces Price Target of $16

Zscaler, TransMedics Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Press releases

From Benzinga Pro

Afya Limited Announces Entering Into a Share Purchase Agreement for the Acquisition of Faculdade Única de Contagem

Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that it has entered into a share purchase

Afya Limited Third Quarter and Nine Months 2024 Financial Results

Impressive Adjusted EBITDA Margin Expansion Robust EPS Expansion Expressive Cash Generation Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical

Afya Limited to Report Third Quarter and Nine Months 2024 Financial Results on November 13th

Afya Limited (NASDAQ:AFYA, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that it will report third-quarter and nine months

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.